Integration of metabolomics and chemometrics with in-silico and in-vitro approaches to unravel SARS-Cov-2 inhibitors from South African plants
Karabo Maselepe Makoana, Clarissa Marcelle Naidoo, Muhammad Sulaiman Zubair, Mmei Cheryl Motshudi, Nqobile Monate Mkolo
PLOS ONE, doi:10.1371/journal.pone.0320415
Coronavirus disease (COVID-19) is still a severe concern, especially in Africa with suboptimal intention rates of vaccination. This flagged the requirement of plant-based remedies as an alternative treatment. In this study we integrated metabolomics and chemometrics approaches with In silico and In vitro approaches to accelerate and unravel compounds from commonly used South African plants that may inhibit SARS-CoV-2 main protease. The selected commonly used plants, Artemisia afra and Artemisia annua, were found to be non-toxic against Vero cells, as determined by the resazurin cell viability assay. Metabolites profiling revealed eighty-one compounds and the top three hit compounds, quercetin 3-O-(6"-acetyl-glucoside), 2"-O-acetylrutin, and quercetin 3-(6"-malonyl-glucoside), had binding affinities of -9.3 kcal/mol, -9.5 kcal/mol, and -9.3 kcal/mol, respectively. The 2"-O-acetyl group of the rutin moiety and quercetin moiety produces a hydrogen bond with the amide nitrogen of His41 and with the side chain carboxylate of Cys145, respectively. Molecular dynamics simulations revealed a stable binding of the docked complexes. In silico observations were validated by In vitro bioassay, which flagged the ability of these compounds to inhibit SARS-CoV-2 3CLpro. The collected analysed data of this study does not only draw special attention to the surfaced 2"-O-acetylrutin as the best suitable inhibitor of SARS-CoV-2 3CLpro, but also indirectly reveals the importance of integrating metabolomics and chemometrics approaches with In silico and In vitro approaches to accelerate and unravel compounds from South African commonly used plants.
Supporting Information
References
Ahmed, Davis, Khan, Prabhakar, Paratap et al., Arq Ajīb: A wonder Unani formulation for inhibiting SARS-CoV-2 spike glycoprotein and main protease-An in silico approach, J Complement Integr Med,
doi:10.1515/jcim-2021-0241Ayoubkhani, Bermingham, Pouwels, Glickman, Nafilyan et al., Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study, BMJ,
doi:10.1136/bmj-2021-069676Banik, Bhattacharjee, Complementation of ROS scavenging secondary metabolites with enzymatic antioxidant defense system augments redox-regulation property under salinity stress in rice, Physiol Mol Biol Plants,
doi:10.1007/s12298-020-00844-9Bepari, Reza, Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation, PeerJ,
doi:10.7717/peerj.11261Bhattacharya, Bordoloi, Chanu, Kalita, Sahariah et al., In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2, J Genet Eng Biotechnol,
doi:10.1186/s43141-022-00314-7Bilia, Santomauro, Sacco, Bergonzi, Donato, Essential Oil of Artemisia annua L.: An Extraordinary Component with Numerous Antimicrobial Properties,
doi:10.1155/2014/159819Blankenship, Yang, Vulupala, Alugubelli, Khatua et al., SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme, ACS Med Chem Lett,
doi:10.1021/acsmedchemlett.4c00146Cannalire, Cerchia, Beccari, Leva, Summa, Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities, J Med Chem,
doi:10.1021/acs.jmedchem.0c01140Cele, Jackson, Khoury, Khan, Moyo-Gwete et al., Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization, Nature,
doi:10.1038/s41586-021-04387-1Chan, Yuan, Kok, To, Chu et al., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet,
doi:10.1016/S0140-6736(20)30154-9Chattopadhyay, Jailani, Mandal, Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness, Vaccines,
doi:10.3390/vaccines11081347Commisso, Strazzer, Toffali, Stocchero, Guzzo, Untargeted metabolomics: an emerging approach to determine the composition of herbal products, Comput Struct Biotechnol J,
doi:10.5936/csbj.201301007Da Rocha, Da Costa, Da, Do, Da Rocha et al., Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation, Front Chem,
doi:10.3389/fchem.2024.1336001Di Pierro, Khan, Bertuccioli, Maffioli, Derosa et al., Quercetin Phytosome® as a potential candidate for managing COVID-19, Minerva Gastroenterol,
doi:10.23736/S2724-5985.20.02771-3Fabre, Rustan, De Hoffmann, Quetin-Leclercq, Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry, J Am Soc Mass Spectrom,
doi:10.1016/S1044-0305(01)00226-4Gillim-Ross, Subbarao, Emerging respiratory viruses: challenges and vaccine strategies, Clin Microbiol Rev,
doi:10.1128/CMR.00005-06Gordon, Jang, Bouhaddou, Xu, Obernier et al., A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, Nature,
doi:10.1038/s41586-020-2286-9Gruessner, Cornet-Vernet, Desrosiers, Lutgen, Towler et al., It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis, Phytochem Rev,
doi:10.1007/s11101-019-09645-9Jendele, Krivak, Skoda, Novotny, Hoksza, PrankWeb: Web server for ligand binding-site prediction and visualization, Nucleic Acids Res,
doi:10.1101/590877Kandeel, Kim, Fayez, Kitade, Kwon, Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease, PeerJ,
doi:10.7717/peerj.12929Koparde, Doijad, Magdum, Natural products in drug discovery
Lai, Nguyen, Investigating structural features of dimeric SARS-CoV-2 Mpro catalytic site with bound covalent ligands at physiological temperature, J Phys: Conf Ser,
doi:10.1088/1742-6596/2485/1/012006Li, Clercq, Muñoz-Fontela, Delgado, Antiviral discovery for highly pathogenic emerging viruses
Li, Liu, Ge, Scientific research progress of COVID-19/SARS-CoV-2 in the first five months, J Cell Mol Med,
doi:10.1111/jcmm.15364Lopez-Leon, Wegman-Ostrosky, Del Valle, Perelman, Sepulveda et al., Long-COVID in children and adolescents: a systematic review and meta-analyses,
doi:10.1038/s41598-022-13495-5Ma, Sacco, Hurst, Townsend, Hu et al., Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease, Cell Res,
doi:10.1038/s41422-020-0356-zMalaterre, Rakoto, Marodon, Bedoui, Nakab et al., Artemisia annua, a Traditional Plant Brought to Light, Int J Mol Sci,
doi:10.3390/ijms21144986Mkolo, Naidoo, Kadye, Obi, Iweriebor et al., Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor,
doi:10.3390/ph17070821Morasso, Costanzi, Demitri, Giabbai, Storici, The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets
Motshudi, Olaokun, Mkolo, Evaluation of GC × GC-TOF-MS untargeted metabolomics, cytotoxicity, and antimicrobial activity of leaf extracts of Artemisia afra (Jacq.) purchased from three local vendors, J King Saud Univ Sci,
doi:10.1016/j.jksus.2021.101422Naidoo, Meyer-Weitz, Govender, Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review, Vaccines,
doi:10.3390/vaccines11040873Oluwaseun, Yinka, Ambrose, Olamide, Adenike et al., Identification of lead inhibitors of TMPRSS2 isoform 1 of SARS-CoV-2 target using neural network, random forest, and molecular docking, Data Science for COVID,
doi:10.1016/b978-0-323-90769-9.00021-9Paul, Islam, Parves, Mamun, Shahriar et al., Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2, J Biomol Struct Dyn,
doi:10.1080/07391102.2020.1831610Prinsloo, Rialet, Carlos, A cell viability assay to determine the cytotoxic effects of water contaminated by microbes, S Afr J Sci
Rehman, Alajmi, Hussain, Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19, Curr Pharm Des,
doi:10.2174/1381612826999201116195851Sallam, COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates, Vaccines,
doi:10.3390/vaccines9020160Schmidtke, Guilloux, Maupetit, Tufféry, fpocket: online tools for protein ensemble pocket detection and tracking, Nucleic Acids Res,
doi:10.1093/nar/gkq383Shinyuy, Loe, Jansen, Mamede, Ledoux et al., Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties-Pharmacokinetics and Pharmacodynamics: A Review, Metabolites,
doi:10.3390/metabo13050613Udofia, Gbayo, Oloba-Whenu, Ogunbayo, Isanbor, In silico studies of selected multidrug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV. Netw Model Anal, Health Inform Bioinform,
doi:10.1007/s13721-021-00299-2Van Doremalen, Bushmaker, Morris, Holbrook, Gamble et al., Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1, N Engl J Med,
doi:10.1056/NEJMc2004973Van Wyk, The potential of South African plants in the development of new medicinal products, South African Journal of Botany,
doi:10.1016/j.sajb.2011.08.011Van Wyk, Van Oudtshoorn, Gericke, Medicinal Plants of South Africa
Verma, Sharma, Kumar, A review on pharmacological properties of Artemisia annua, Journal of Pharmacognosy and Phytochemistry
Vijayarathna, Sasidharan, Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines, Asian Pac J Trop Biomed,
doi:10.1016/S2221-1691(12)60237-8Willcox, Artemisia species: From traditional medicines to modern antimalarials--and back again, J Altern Complement Med,
doi:10.1089/acm.2008.0327Worldmeter, Worldwide COVID-19 confirmed cases, deaths and recovery rates
Zhu, Zhang, Li, Yang, Song, A Novel Coronavirus from Patients with Pneumonia in China, N Engl J Med,
doi:10.1056/NEJMoa2001017DOI record:
{
"DOI": "10.1371/journal.pone.0320415",
"ISSN": [
"1932-6203"
],
"URL": "http://dx.doi.org/10.1371/journal.pone.0320415",
"abstract": "<jats:p>Coronavirus disease (COVID-19) is still a severe concern, especially in Africa with suboptimal intention rates of vaccination. This flagged the requirement of plant-based remedies as an alternative treatment. In this study we integrated metabolomics and chemometrics approaches with In silico and In vitro approaches to accelerate and unravel compounds from commonly used South African plants that may inhibit SARS-CoV-2 main protease. The selected commonly used plants, <jats:italic>Artemisia afra</jats:italic> and <jats:italic>Artemisia annua</jats:italic>, were found to be non-toxic against Vero cells, as determined by the resazurin cell viability assay. Metabolites profiling revealed eighty-one compounds and the top three hit compounds, quercetin 3-O-(6“-acetyl-glucoside), 2”-O-acetylrutin, and quercetin 3-(6”-malonyl-glucoside), had binding affinities of -9.3 kcal/mol, -9.5 kcal/mol, and -9.3 kcal/mol, respectively. The 2”-O-acetyl group of the rutin moiety and quercetin moiety produces a hydrogen bond with the amide nitrogen of His41 and with the side chain carboxylate of Cys145, respectively. Molecular dynamics simulations revealed a stable binding of the docked complexes. In silico observations were validated by In vitro bioassay, which flagged the ability of these compounds to inhibit SARS-CoV-2 3CLpro. The collected analysed data of this study does not only draw special attention to the surfaced 2”-O-acetylrutin as the best suitable inhibitor of SARS-CoV-2 3CLpro, but also indirectly reveals the importance of integrating metabolomics and chemometrics approaches with In silico and In vitro approaches to accelerate and unravel compounds from South African commonly used plants.</jats:p>",
"author": [
{
"affiliation": [],
"family": "Makoana",
"given": "Karabo Maselepe",
"sequence": "first"
},
{
"ORCID": "https://orcid.org/0000-0001-9164-8213",
"affiliation": [],
"authenticated-orcid": true,
"family": "Naidoo",
"given": "Clarissa Marcelle",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Zubair",
"given": "Muhammad Sulaiman",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Motshudi",
"given": "Mmei Cheryl",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0003-3631-4522",
"affiliation": [],
"authenticated-orcid": true,
"family": "Mkolo",
"given": "Nqobile Monate",
"sequence": "additional"
}
],
"container-title": "PLOS ONE",
"container-title-short": "PLoS ONE",
"content-domain": {
"crossmark-restriction": false,
"domain": [
"www.plosone.org"
]
},
"created": {
"date-parts": [
[
2025,
3,
26
]
],
"date-time": "2025-03-26T21:07:23Z",
"timestamp": 1743023243000
},
"deposited": {
"date-parts": [
[
2025,
3,
26
]
],
"date-time": "2025-03-26T21:11:14Z",
"timestamp": 1743023474000
},
"editor": [
{
"affiliation": [],
"family": "Al-Karmalawy",
"given": "Ahmed A.",
"sequence": "first"
}
],
"funder": [
{
"DOI": "10.13039/501100001322",
"award": [
"MKOLO24/25"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100001322",
"id-type": "DOI"
}
],
"name": "South African Medical Research Council"
}
],
"indexed": {
"date-parts": [
[
2025,
3,
26
]
],
"date-time": "2025-03-26T21:40:25Z",
"timestamp": 1743025225511,
"version": "3.40.3"
},
"is-referenced-by-count": 0,
"issue": "3",
"issued": {
"date-parts": [
[
2025,
3,
26
]
]
},
"journal-issue": {
"issue": "3",
"published-online": {
"date-parts": [
[
2025,
3,
26
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
26
]
],
"date-time": "2025-03-26T00:00:00Z",
"timestamp": 1742947200000
}
}
],
"link": [
{
"URL": "https://dx.plos.org/10.1371/journal.pone.0320415",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "340",
"original-title": [],
"page": "e0320415",
"prefix": "10.1371",
"published": {
"date-parts": [
[
2025,
3,
26
]
]
},
"published-online": {
"date-parts": [
[
2025,
3,
26
]
]
},
"publisher": "Public Library of Science (PLoS)",
"reference": [
{
"article-title": "Coronavirus disease (COVID-19) situation report 52 [Internet].",
"author": "World Health Organization (WHO)",
"key": "pone.0320415.ref001"
},
{
"DOI": "10.1056/NEJMc2004973",
"article-title": "Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1",
"author": "N van Doremalen",
"doi-asserted-by": "crossref",
"first-page": "1564",
"issue": "16",
"journal-title": "N Engl J Med",
"key": "pone.0320415.ref002",
"volume": "382",
"year": "2020"
},
{
"article-title": "COVID-19 vaccine uptake and access [Internet].",
"author": "World Health Organization (WHO)",
"key": "pone.0320415.ref003"
},
{
"article-title": "Worldwide COVID-19 confirmed cases, deaths and recovery rates.",
"author": "Worldmeter",
"key": "pone.0320415.ref004"
},
{
"DOI": "10.1056/NEJMoa2001017",
"article-title": "A Novel Coronavirus from Patients with Pneumonia in China, 2019",
"author": "N Zhu",
"doi-asserted-by": "crossref",
"first-page": "727",
"issue": "8",
"journal-title": "N Engl J Med",
"key": "pone.0320415.ref005",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1080/10408363.2020.1783198",
"article-title": "The COVID-19 pandemic",
"author": "M Ciotti",
"doi-asserted-by": "crossref",
"first-page": "365",
"issue": "6",
"journal-title": "Crit Rev Clin Lab Sci",
"key": "pone.0320415.ref006",
"volume": "57",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30154-9",
"article-title": "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster",
"author": "JF-W Chan",
"doi-asserted-by": "crossref",
"first-page": "514",
"issue": "10223",
"journal-title": "Lancet",
"key": "pone.0320415.ref007",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1111/jcmm.15364",
"article-title": "Scientific research progress of COVID-19/SARS-CoV-2 in the first five months",
"author": "H Li",
"doi-asserted-by": "crossref",
"first-page": "6558",
"issue": "12",
"journal-title": "J Cell Mol Med",
"key": "pone.0320415.ref008",
"volume": "24",
"year": "2020"
},
{
"DOI": "10.35772/ghm.2021.01010",
"article-title": "COVID-19 vaccines: implementation, limitations and opportunities",
"author": "DD Richman",
"doi-asserted-by": "crossref",
"first-page": "1",
"issue": "1",
"journal-title": "Glob Health Med",
"key": "pone.0320415.ref009",
"volume": "3",
"year": "2021"
},
{
"DOI": "10.3390/vaccines11081347",
"article-title": "Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness",
"author": "A Chattopadhyay",
"doi-asserted-by": "crossref",
"first-page": "1347",
"issue": "8",
"journal-title": "Vaccines (Basel)",
"key": "pone.0320415.ref010",
"volume": "11",
"year": "2023"
},
{
"DOI": "10.1128/CMR.00005-06",
"article-title": "Emerging respiratory viruses: challenges and vaccine strategies",
"author": "L Gillim-Ross",
"doi-asserted-by": "crossref",
"first-page": "614",
"issue": "4",
"journal-title": "Clin Microbiol Rev",
"key": "pone.0320415.ref011",
"volume": "19",
"year": "2006"
},
{
"DOI": "10.3390/vaccines10020138",
"article-title": "Plant-Based Vaccines in Combat against Coronavirus Diseases",
"author": "B Ortega-Berlanga",
"doi-asserted-by": "crossref",
"first-page": "138",
"issue": "2",
"journal-title": "Vaccines (Basel)",
"key": "pone.0320415.ref012",
"volume": "10",
"year": "2022"
},
{
"DOI": "10.3390/vaccines11040873",
"article-title": "Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review",
"author": "D Naidoo",
"doi-asserted-by": "crossref",
"first-page": "873",
"issue": "4",
"journal-title": "Vaccines (Basel)",
"key": "pone.0320415.ref013",
"volume": "11",
"year": "2023"
},
{
"DOI": "10.3390/vaccines9020160",
"article-title": "COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates",
"author": "M Sallam",
"doi-asserted-by": "crossref",
"first-page": "160",
"issue": "2",
"journal-title": "Vaccines (Basel)",
"key": "pone.0320415.ref014",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1038/d41586-022-01730-y",
"article-title": "What Omicron’s BA.4 and BA.5 variants mean for the pandemic",
"author": "E Callaway",
"doi-asserted-by": "crossref",
"first-page": "848",
"issue": "7916",
"journal-title": "Nature",
"key": "pone.0320415.ref015",
"volume": "606",
"year": "2022"
},
{
"DOI": "10.1038/s41586-021-04387-1",
"article-title": "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization",
"author": "S Cele",
"doi-asserted-by": "crossref",
"first-page": "654",
"issue": "7898",
"journal-title": "Nature",
"key": "pone.0320415.ref016",
"volume": "602",
"year": "2021"
},
{
"DOI": "10.1038/s41598-022-13495-5",
"article-title": "Long-COVID in children and adolescents: a systematic review and meta-analyses",
"author": "S Lopez-Leon",
"doi-asserted-by": "crossref",
"first-page": "9950",
"issue": "1",
"journal-title": "Sci Rep",
"key": "pone.0320415.ref017",
"volume": "12",
"year": "2022"
},
{
"DOI": "10.1136/bmj-2021-069676",
"article-title": "Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study",
"author": "D Ayoubkhani",
"doi-asserted-by": "crossref",
"first-page": "e069676",
"journal-title": "BMJ",
"key": "pone.0320415.ref018",
"volume": "377",
"year": "2022"
},
{
"article-title": "Antiviral discovery for highly pathogenic emerging viruses.",
"author": "G Li",
"key": "pone.0320415.ref019",
"volume-title": "Antiviral discovery for highly pathogenic emerging viruses",
"year": "2021"
},
{
"DOI": "10.1021/acs.jmedchem.0c01140",
"article-title": "Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities",
"author": "R Cannalire",
"doi-asserted-by": "crossref",
"first-page": "2716",
"issue": "4",
"journal-title": "J Med Chem",
"key": "pone.0320415.ref020",
"volume": "65",
"year": "2022"
},
{
"DOI": "10.1038/s41586-020-2286-9",
"article-title": "A SARS-CoV-2 protein interaction map reveals targets for drug repurposing",
"author": "DE Gordon",
"doi-asserted-by": "crossref",
"first-page": "459",
"issue": "7816",
"journal-title": "Nature",
"key": "pone.0320415.ref021",
"volume": "583",
"year": "2020"
},
{
"DOI": "10.1038/s41422-020-0356-z",
"article-title": "Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease",
"author": "C Ma",
"doi-asserted-by": "crossref",
"first-page": "678",
"issue": "8",
"journal-title": "Cell Res",
"key": "pone.0320415.ref022",
"volume": "30",
"year": "2020"
},
{
"DOI": "10.3390/metabo13050613",
"article-title": "Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties-Pharmacokinetics and Pharmacodynamics: A Review",
"author": "LM Shinyuy",
"doi-asserted-by": "crossref",
"first-page": "613",
"issue": "5",
"journal-title": "Metabolites",
"key": "pone.0320415.ref023",
"volume": "13",
"year": "2023"
},
{
"DOI": "10.3390/ijms21144986",
"article-title": "Artemisia annua, a Traditional Plant Brought to Light",
"author": "A Septembre-Malaterre",
"doi-asserted-by": "crossref",
"first-page": "4986",
"issue": "14",
"journal-title": "Int J Mol Sci",
"key": "pone.0320415.ref024",
"volume": "21",
"year": "2020"
},
{
"DOI": "10.1007/s11101-019-09645-9",
"article-title": "It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis",
"author": "BM Gruessner",
"doi-asserted-by": "crossref",
"first-page": "1509",
"issue": "6",
"journal-title": "Phytochem Rev",
"key": "pone.0320415.ref025",
"volume": "18",
"year": "2019"
},
{
"DOI": "10.1016/j.sajb.2011.08.011",
"article-title": "The potential of South African plants in the development of new medicinal products",
"author": "B-E Van Wyk",
"doi-asserted-by": "crossref",
"first-page": "812",
"issue": "4",
"journal-title": "South African Journal of Botany",
"key": "pone.0320415.ref026",
"volume": "77",
"year": "2011"
},
{
"author": "B Van Wyk",
"key": "pone.0320415.ref027",
"volume-title": "Medicinal Plants of South Africa",
"year": "1997"
},
{
"DOI": "10.1016/B978-0-323-99794-2.00016-7",
"article-title": "Artemisia afra",
"author": "Z Sotenjwa",
"doi-asserted-by": "crossref",
"first-page": "83",
"journal-title": "The South African Herbal Pharmacopoeia",
"key": "pone.0320415.ref028",
"year": "2023"
},
{
"article-title": "A review on pharmacological properties of Artemisia annua",
"author": "M Verma",
"first-page": "2179",
"issue": "4",
"journal-title": "Journal of Pharmacognosy and Phytochemistry",
"key": "pone.0320415.ref029",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.1089/acm.2008.0327",
"article-title": "Artemisia species: From traditional medicines to modern antimalarials--and back again",
"author": "M Willcox",
"doi-asserted-by": "crossref",
"first-page": "101",
"issue": "2",
"journal-title": "J Altern Complement Med",
"key": "pone.0320415.ref030",
"volume": "15",
"year": "2009"
},
{
"DOI": "10.1016/B978-0-12-823779-3.00004-7",
"article-title": "Artemisia afra",
"author": "A Viljoen",
"doi-asserted-by": "crossref",
"first-page": "39",
"journal-title": "Phytochemical Profiling of Commercially Important South African Plants",
"key": "pone.0320415.ref031",
"year": "2022"
},
{
"article-title": "A cell viability assay to determine the cytotoxic effects of water contaminated by microbes",
"author": "S Prinsloo",
"first-page": "1",
"issue": "5–6",
"journal-title": "S Afr J Sci",
"key": "pone.0320415.ref032",
"volume": "109",
"year": "2013"
},
{
"DOI": "10.1016/S1044-0305(01)00226-4",
"article-title": "Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry",
"author": "N Fabre",
"doi-asserted-by": "crossref",
"first-page": "707",
"issue": "6",
"journal-title": "J Am Soc Mass Spectrom",
"key": "pone.0320415.ref033",
"volume": "12",
"year": "2001"
},
{
"article-title": "Identification of lead inhibitors of TMPRSS2 isoform 1 of SARS-CoV-2 target using neural network, random forest, and molecular docking",
"author": "AS Oluwaseun",
"first-page": "547",
"journal-title": "Data Science for COVID-19",
"key": "pone.0320415.ref034",
"year": "2022"
},
{
"DOI": "10.5772/intechopen.82860",
"article-title": "Natural products in drug discovery.",
"author": "A Amit Koparde",
"doi-asserted-by": "crossref",
"first-page": "269",
"key": "pone.0320415.ref035",
"volume-title": "Pharmacognosy-Medicinal Plants",
"year": "2019"
},
{
"DOI": "10.1016/S2221-1691(12)60237-8",
"article-title": "Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines",
"author": "S Vijayarathna",
"doi-asserted-by": "crossref",
"first-page": "826",
"issue": "10",
"journal-title": "Asian Pac J Trop Biomed",
"key": "pone.0320415.ref036",
"volume": "2",
"year": "2012"
},
{
"DOI": "10.1155/2014/159819",
"article-title": "Essential Oil of Artemisia annua L.: An Extraordinary Component with Numerous Antimicrobial Properties",
"author": "AR Bilia",
"doi-asserted-by": "crossref",
"first-page": "159819",
"journal-title": "Evid Based Complement Alternat Med",
"key": "pone.0320415.ref037",
"year": "2014"
},
{
"DOI": "10.1016/j.jksus.2021.101422",
"article-title": "Evaluation of GC × GC-TOF-MS untargeted metabolomics, cytotoxicity, and antimicrobial activity of leaf extracts of Artemisia afra (Jacq.) purchased from three local vendors.",
"author": "MC Motshudi",
"doi-asserted-by": "crossref",
"key": "pone.0320415.ref038",
"year": "2021"
},
{
"DOI": "10.5936/csbj.201301007",
"article-title": "Untargeted metabolomics: an emerging approach to determine the composition of herbal products",
"author": "M Commisso",
"doi-asserted-by": "crossref",
"first-page": "e201301007",
"journal-title": "Comput Struct Biotechnol J",
"key": "pone.0320415.ref039",
"volume": "4",
"year": "2013"
},
{
"DOI": "10.1016/j.compbiomed.2021.104851",
"article-title": "In silico methods and tools for drug discovery",
"author": "B Shaker",
"doi-asserted-by": "crossref",
"first-page": "104851",
"journal-title": "Comput Biol Med",
"key": "pone.0320415.ref040",
"volume": "137",
"year": "2021"
},
{
"DOI": "10.2174/1389450121666201119141525",
"article-title": "An Overview of Computer-aided Drug Design Tools and Recent Applications in Designing of Anti-diabetic Agents",
"author": "P Kaur",
"doi-asserted-by": "crossref",
"first-page": "1158",
"issue": "10",
"journal-title": "Curr Drug Targets",
"key": "pone.0320415.ref041",
"volume": "22",
"year": "2021"
},
{
"DOI": "10.1093/nar/gkz424",
"article-title": "PrankWeb: Web server for ligand binding-site prediction and visualization.",
"author": "L Jendele",
"doi-asserted-by": "crossref",
"key": "pone.0320415.ref042",
"year": "2019"
},
{
"DOI": "10.1093/nar/gkq383",
"article-title": "fpocket: online tools for protein ensemble pocket detection and tracking",
"author": "P Schmidtke",
"doi-asserted-by": "crossref",
"first-page": "W582",
"issue": "Web Server issue",
"journal-title": "Nucleic Acids Res",
"key": "pone.0320415.ref043",
"volume": "38",
"year": "2010"
},
{
"DOI": "10.1021/acsmedchemlett.4c00146",
"article-title": "SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme",
"author": "LR Blankenship",
"doi-asserted-by": "crossref",
"first-page": "950",
"issue": "6",
"journal-title": "ACS Med Chem Lett",
"key": "pone.0320415.ref044",
"volume": "15",
"year": "2024"
},
{
"DOI": "10.3389/fchem.2024.1336001",
"article-title": "Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation",
"author": "JAP da Rocha",
"doi-asserted-by": "crossref",
"first-page": "1336001",
"journal-title": "Front Chem",
"key": "pone.0320415.ref045",
"volume": "12",
"year": "2024"
},
{
"DOI": "10.1007/978-3-031-30691-4_7",
"article-title": "The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets.",
"author": "S Morasso",
"doi-asserted-by": "crossref",
"key": "pone.0320415.ref046",
"volume-title": "Exscalate4CoV. SpringerBriefs in Applied Sciences and Technology",
"year": "2023"
},
{
"DOI": "10.1007/s12298-020-00844-9",
"article-title": "Complementation of ROS scavenging secondary metabolites with enzymatic antioxidant defense system augments redox-regulation property under salinity stress in rice",
"author": "N Banik",
"doi-asserted-by": "crossref",
"first-page": "1623",
"issue": "8",
"journal-title": "Physiol Mol Biol Plants",
"key": "pone.0320415.ref047",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1080/07391102.2020.1831610",
"article-title": "Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2",
"author": "AS Paul",
"doi-asserted-by": "crossref",
"first-page": "1639",
"issue": "4",
"journal-title": "J Biomol Struct Dyn",
"key": "pone.0320415.ref048",
"volume": "40",
"year": "2022"
},
{
"article-title": "Investigating structural features of dimeric SARS-CoV-2 Mpro catalytic site with bound covalent ligands at physiological temperature",
"author": "HTT Lai",
"first-page": "012006",
"issue": "1",
"journal-title": "J Phys: Conf Ser",
"key": "pone.0320415.ref049",
"year": "2023"
},
{
"DOI": "10.1186/s43141-022-00314-7",
"article-title": "In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2",
"author": "K Bhattacharya",
"doi-asserted-by": "crossref",
"first-page": "43",
"issue": "1",
"journal-title": "J Genet Eng Biotechnol",
"key": "pone.0320415.ref050",
"volume": "20",
"year": "2022"
},
{
"DOI": "10.1007/s13721-021-00299-2",
"article-title": "In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV",
"author": "IA Udofia",
"doi-asserted-by": "crossref",
"first-page": "22",
"issue": "1",
"journal-title": "Netw Model Anal Health Inform Bioinform",
"key": "pone.0320415.ref051",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.7717/peerj.11261",
"article-title": "Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation",
"author": "AK Bepari",
"doi-asserted-by": "crossref",
"first-page": "e11261",
"journal-title": "PeerJ",
"key": "pone.0320415.ref052",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.2174/1381612826999201116195851",
"article-title": "Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19",
"author": "MT Rehman",
"doi-asserted-by": "crossref",
"first-page": "3577",
"issue": "33",
"journal-title": "Curr Pharm Des",
"key": "pone.0320415.ref053",
"volume": "27",
"year": "2021"
},
{
"article-title": "Arq Ajīb: A wonder Unani formulation for inhibiting SARS-CoV-2 spike glycoprotein and main protease—An in silico approach.",
"author": "NZ Ahmed",
"key": "pone.0320415.ref054"
},
{
"DOI": "10.3390/ph17070821",
"article-title": "Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor",
"author": "NM Mkolo",
"doi-asserted-by": "crossref",
"first-page": "821",
"issue": "7",
"journal-title": "Pharmaceuticals (Basel)",
"key": "pone.0320415.ref055",
"volume": "17",
"year": "2024"
},
{
"DOI": "10.7717/peerj.12929",
"article-title": "Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease",
"author": "M Kandeel",
"doi-asserted-by": "crossref",
"first-page": "e12929",
"journal-title": "PeerJ",
"key": "pone.0320415.ref056",
"volume": "10",
"year": "2022"
},
{
"article-title": "Quercetin Phytosome® as a potential candidate for managing COVID-19",
"author": "F DI Pierro",
"first-page": "190",
"issue": "2",
"journal-title": "Minerva Gastroenterol (Torino)",
"key": "pone.0320415.ref057",
"volume": "67",
"year": "2021"
}
],
"reference-count": 57,
"references-count": 57,
"relation": {},
"resource": {
"primary": {
"URL": "https://dx.plos.org/10.1371/journal.pone.0320415"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Integration of metabolomics and chemometrics with in-silico and in-vitro approaches to unravel SARS-Cov-2 inhibitors from South African plants",
"type": "journal-article",
"update-policy": "https://doi.org/10.1371/journal.pone.corrections_policy",
"volume": "20"
}
